The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Deadly brain disease could be treated in the womb with gene therapy

| | July 25, 2018

A research team from the UK and Singapore showed that a neurodegenerative condition called Gaucher disease, which can be fatal, can be prevented in mice by treating fetuses with gene therapy.

The study, published in Nature Medicine, showed mice fetuses with Gaucher disease that received an injection of the gene therapy were able to express the missing enzyme. Furthermore, animals treated with the gene therapy lived for four and a half months after birth compared to 15 days for untreated mice.

While the findings underscore the potential of using gene therapy to prevent and cure fetal diseases in humans in utero, the approach is still a long way from being tested in humans.

Related article:  Duchenne muscular dystrophy gene therapy trial put on hold

Read full, original post: Gene Therapy Could Prevent Deadly Brain Disease


The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend